Akeso begins patient enrollment in phase 3 trial of ivonescimab combination as first-line therapy for biliary tract tumours, compared to durvalumab: China Monday, November 4, 2024 ...
Theriva Biologics selected as finalist in international competition for Merck KGaA's EMEA Advance Biotech Grant: Rockville, Maryland Monday, November 4, 2024, 16:00 Hrs [IST] Ther ...
NIH study demonstrates long-term benefits of weight-loss surgery in young people: Bethesda, Maryland Monday, November 4, 2024, 18:00 Hrs [IST] Young people with severe obesity who ...
Illumina to present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at ASHG meeting: San Diego Monday, November 4, 2024, 17:0 ...
Nandita Vijayasimha, Bengaluru Monday, November 4, 2024, 08:00 Hrs [IST] ...
Verastem Oncology submits NDA to US FDA for avutometinib plus defactinib to treat recurrent KRAS mutant low-grade serous ovarian cancer: Boston Monday, November 4, 2024, 14:00 Hrs ...
BioRestorative Therapies’ ThermoStem metabolic disease programme receives Israeli patent: Melville, New York Monday, November 4, 2024, 15:00 Hrs [IST] BioRestorative Therapies, ...
ICMR invites expression of interest for technology transfer to commercialize monkeypox detection assay: Shardul Nautiyal, ...
ICDRA created a concept of harmonisation among all drug regulators all over the world: Dr D Roy: Our Bureau, Chennai Monday, November 4, 2024, 09:00 Hrs [IST] Evaluating the ...
Gireesh Babu, New Delhi Monday, November 4, 2024, 08:00 Hrs [IST] The Jan Aushadhi Kendras (JAKs), under the Departme ...
No legal provision for separate licence for pharmaceutical marketers: TN drug controller: Peethaambaran Kunnathoor, Chennai Monday, November 4, 2024, 08:00 Hrs [IST] The drug cont ...
Ayush Ministry amends Rules to mandate renewal of manufacturing & loan license to perpetuity: Gireesh Babu, New Delhi Monday, November 4, 2024, 08:00 Hrs [IST] The Union Ministry ...